Earnings News - Candlesense

Oblong Reports Q2 2025 Results and Expands $8M TAO Treasury to Power Decentralized AI

DENVER--(BUSINESS WIRE)--Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), a digital asset treasury company, today announced financial results for the second quarter ended June 30, 2025 (“Q2...

What are the potential upside and downside scenarios for the TAO token price and its effect on the company's market cap? How does the company's current debt and liquidity position support the expanded TAO commitment? What is the expected impact on the stock’s volatility and trading volume in the short term?

Symbol: OBLG

27 days ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today annou...

What is the market's reaction to the earnings surprise (if any), and what are the short‑term price targets from analysts? Are there any insider transactions or recent changes in institutional ownership following the release? How does Nuwellis' valuation metrics (P/E, EV/EBITDA, price-to-sales) compare to peers in the medical technology sector?

Symbol: NUWE

27 days ago

Read more globenewswire

Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins

REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the ...

What are the potential risks or headwinds (e.g., competition, reimbursement changes, tech adoption rates) that could affect future earnings? How sensitive is the company's profitability to scaling of AI and automation technologies? What is the composition of Biotricity's customer base (e.g., hospitals, insurers, consumers) and are there concentration risks?

Symbol: BTCY

27 days ago

Read more globenewswire

Perpetua Resources Announces Second Quarter 2025 and Recent Highlights

BOISE, Idaho, Aug. 14, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed con...

What potential macro‑economic or geopolitical factors could amplify or mitigate the implications of this earnings report on the stock? Are there any forward‑looking statements regarding commodity price exposure or hedging strategies that could impact future profitability? What is the market’s reaction to the earnings release (e.g., price movement, volume) and does it suggest a shift in sentiment?

Symbol: PPTA

27 days ago

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

NEEDHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal bio...

Are there any macro‑economic or sector‑specific trends (e.g., biotech funding environment, cancer‑therapy market demand) that could amplify or mitigate the impact of this release on CADL's stock? What is the current short‑interest level on CADL, and could the news trigger short covering or increased short‑selling activity? How does the sentiment score of 10 align with market expectations, and could this indicate a potential over‑ or under‑reaction in the stock price?

Symbol: CADL

27 days ago

Read more globenewswire

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update

ISELIN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment ...

What is the market's perception of Outlook Therapeutics' competitive positioning against other bevacizumab‑based or alternative retinal disease treatments? How did the share price react to the press release historically, and what is the typical intraday volatility around such announcements? Is there any indication of partnership or licensing discussions with larger pharma companies that could provide upside?

Symbol: OTLK

27 days ago

Read more globenewswire

NextPlat Reports Second Quarter 2025 Results

Company Reports $13.2M in Q2 Revenue, Achieves Significant Reduction in Operating Expenses and Continues Cost Reduction and Efficiency Improvements to Support Growth COCONUT GROVE, Fla., Aug. 14, 2...

What risks or uncertainties were highlighted in the Management Discussion and Analysis section that could affect future performance? Did the release mention any new product launches, partnerships, or market expansion plans that could drive growth? How does NextPlat's performance stack up against key competitors in the same sector?

Symbol: NXPL

27 days ago

Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and six months ended June 30, 2025, ...

What is the implied breakeven point for the antiviral programs based on current cost structure and projected market size? Are there any non‑financial risks (e.g., legal, IP, manufacturing) mentioned that could affect the company's outlook? What is the historical performance of Cocrystal's stock around earnings releases and how does that inform expected price movement?

Symbol: COCP

27 days ago

Read more globenewswire

Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability

WESTBROOK, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for ...

What is the analyst consensus rating and target price, and how might this release shift those expectations? How might the earnings beat/ miss affect short‑term stock price volatility and trading volume? What is the outlook for the next quarter and any potential catalysts or risks mentioned?

Symbol: SNYR

27 days ago

Read more globenewswire

GlobalTech Corporation Announces Second Quarter 2025 Results

RENO, Nev., Aug. 14, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTCID:GTLK) (“GlobalTech” or the “Company”), a technology holding company specializing in artificial intelligence (AI) and bi...

Are there any insider transactions or institutional ownership changes reported around the release date? What macro‑economic or regulatory factors could influence GlobalTech's performance in the upcoming quarters? How does the reported sentiment score of 0 influence market perception and analyst sentiment?

Symbol: GTLK

27 days ago

Read more globenewswire